Literature DB >> 32780879

Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade.

Herbert Tilg1, Timon E Adolph1, Alexander R Moschen1.   

Abstract

Entities:  

Year:  2021        PMID： 32780879      PMCID： PMC7898624          DOI： 10.1002/hep.31518

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  92 in total

Review 1.  Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.

Authors:  Annika Wahlström; Sama I Sayin; Hanns-Ulrich Marschall; Fredrik Bäckhed
Journal:  Cell Metab       Date:  2016-06-16       Impact factor: 27.287

2.  Fermentation Products of Commensal Bacteria Alter Enterocyte Lipid Metabolism.

Authors:  João R Araújo; Asmaa Tazi; Odile Burlen-Defranoux; Sophie Vichier-Guerre; Giulia Nigro; Hélène Licandro; Sylvie Demignot; Philippe J Sansonetti
Journal:  Cell Host Microbe       Date:  2020-02-25       Impact factor: 21.023

3.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

Authors:  Lixin Zhu; Susan S Baker; Chelsea Gill; Wensheng Liu; Razan Alkhouri; Robert D Baker; Steven R Gill
Journal:  Hepatology       Date:  2013-01-08       Impact factor: 17.425

4.  Adipose type I interferon signalling protects against metabolic dysfunction.

Authors:  Verena Wieser; Timon Erik Adolph; Christoph Grander; Felix Grabherr; Barbara Enrich; Patrizia Moser; Alexander Rupert Moschen; Susanne Kaser; Herbert Tilg
Journal:  Gut       Date:  2016-12-23       Impact factor: 23.059

Review 5.  NAFLD as a driver of chronic kidney disease.

Authors:  Christopher D Byrne; Giovanni Targher
Journal:  J Hepatol       Date:  2020-02-12       Impact factor: 25.083

6.  Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.

Authors:  Rohit Loomba; Victor Seguritan; Weizhong Li; Tao Long; Niels Klitgord; Archana Bhatt; Parambir Singh Dulai; Cyrielle Caussy; Richele Bettencourt; Sarah K Highlander; Marcus B Jones; Claude B Sirlin; Bernd Schnabl; Lauren Brinkac; Nicholas Schork; Chi-Hua Chen; David A Brenner; William Biggs; Shibu Yooseph; J Craig Venter; Karen E Nelson
Journal:  Cell Metab       Date:  2017-05-02       Impact factor: 27.287

7.  IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.

Authors:  G S Hotamisligil; P Peraldi; A Budavari; R Ellis; M F White; B M Spiegelman
Journal:  Science       Date:  1996-02-02       Impact factor: 47.728

8.  Dietary trans-fatty acid induced NASH is normalized following loss of trans-fatty acids from hepatic lipid pools.

Authors:  Brent A Neuschwander-Tetri; David A Ford; Sahaja Acharya; George Gilkey; Metin Basaranoglu; Laura H Tetri; Elizabeth M Brunt
Journal:  Lipids       Date:  2012-08-26       Impact factor: 1.880

Review 9.  Metabolic interplay between white, beige, brown adipocytes and the liver.

Authors:  Ludger Scheja; Joerg Heeren
Journal:  J Hepatol       Date:  2016-01-30       Impact factor: 25.083

10.  Phosphorylation of Beta-3 adrenergic receptor at serine 247 by ERK MAP kinase drives lipolysis in obese adipocytes.

Authors:  Shangyu Hong; Wei Song; Peter-James H Zushin; Bingyang Liu; Mark P Jedrychowski; Amir I Mina; Zhaoming Deng; Dimitrije Cabarkapa; Jessica A Hall; Colin J Palmer; Hassan Aliakbarian; John Szpyt; Steven P Gygi; Ali Tavakkoli; Lydia Lynch; Norbert Perrimon; Alexander S Banks
Journal:  Mol Metab       Date:  2018-03-29       Impact factor: 7.422
View more
  46 in total

1.  Active p38α causes macrovesicular fatty liver in mice.

Authors:  Ilona Darlyuk-Saadon; Chen Bai; Chew Kiat Matthew Heng; Nechama Gilad; Wei-Ping Yu; Pei Yen Lim; Amaury Cazenave-Gassiot; Yongliang Zhang; W S Fred Wong; David Engelberg
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

Review 2.  Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity.

Authors:  Herbert Tilg; Timon E Adolph; Michael Dudek; Percy Knolle
Journal:  Nat Metab       Date:  2021-12-20

Review 3.  Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease.

Authors:  Philippe Lefebvre; Bart Staels
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

4.  A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation.

Authors:  Marijana Vujkovic; Shweta Ramdas; Daniel J Rader; Benjamin F Voight; Kyong-Mi Chang; Kim M Lorenz; Xiuqing Guo; Rebecca Darlay; Heather J Cordell; Jing He; Yevgeniy Gindin; Chuhan Chung; Robert P Myers; Carolin V Schneider; Joseph Park; Kyung Min Lee; Marina Serper; Rotonya M Carr; David E Kaplan; Mary E Haas; Matthew T MacLean; Walter R Witschey; Xiang Zhu; Catherine Tcheandjieu; Rachel L Kember; Henry R Kranzler; Anurag Verma; Ayush Giri; Derek M Klarin; Yan V Sun; Jie Huang; Jennifer E Huffman; Kate Townsend Creasy; Nicholas J Hand; Ching-Ti Liu; Michelle T Long; Jie Yao; Matthew Budoff; Jingyi Tan; Xiaohui Li; Henry J Lin; Yii-Der Ida Chen; Kent D Taylor; Ruey-Kang Chang; Ronald M Krauss; Silvia Vilarinho; Joseph Brancale; Jonas B Nielsen; Adam E Locke; Marcus B Jones; Niek Verweij; Aris Baras; K Rajender Reddy; Brent A Neuschwander-Tetri; Jeffrey B Schwimmer; Arun J Sanyal; Naga Chalasani; Kathleen A Ryan; Braxton D Mitchell; Dipender Gill; Andrew D Wells; Elisabetta Manduchi; Yedidya Saiman; Nadim Mahmud; Donald R Miller; Peter D Reaven; Lawrence S Phillips; Sumitra Muralidhar; Scott L DuVall; Jennifer S Lee; Themistocles L Assimes; Saiju Pyarajan; Kelly Cho; Todd L Edwards; Scott M Damrauer; Peter W Wilson; J Michael Gaziano; Christopher J O'Donnell; Amit V Khera; Struan F A Grant; Christopher D Brown; Philip S Tsao; Danish Saleheen; Luca A Lotta; Lisa Bastarache; Quentin M Anstee; Ann K Daly; James B Meigs; Jerome I Rotter; Julie A Lynch
Journal:  Nat Genet       Date:  2022-06-02       Impact factor: 41.307

5.  Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice.

Authors:  Moritz Helmstädter; Jurema Schmidt; Astrid Kaiser; Lilia Weizel; Ewgenij Proschak; Daniel Merk
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-29

Review 6.  Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.

Authors:  Pau Vancells Lujan; Esther Viñas Esmel; Emilio Sacanella Meseguer
Journal:  Nutrients       Date:  2021-04-24       Impact factor: 5.717

Review 7.  The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD.

Authors:  Emmanuel D Dixon; Alexander D Nardo; Thierry Claudel; Michael Trauner
Journal:  Genes (Basel)       Date:  2021-04-26       Impact factor: 4.096

Review 8.  From the origin of NASH to the future of metabolic fatty liver disease.

Authors:  Andreas Geier; Dina Tiniakos; Helmut Denk; Michael Trauner
Journal:  Gut       Date:  2021-02-25       Impact factor: 23.059

9.  The Association between Decreased Kidney Function and FIB-4 Index Value, as Indirect Liver Fibrosis Indicator, in Middle-Aged and Older Subjects.

Authors:  Kazuko Kotoku; Ryoma Michishita; Takuro Matsuda; Shotaro Kawakami; Natsumi Morito; Yoshinari Uehara; Yasuki Higaki
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

Review 10.  Role of Leptin in Non-Alcoholic Fatty Liver Disease.

Authors:  Carlos Jiménez-Cortegana; Alba García-Galey; Malika Tami; Pilar Del Pino; Isabel Carmona; Soledad López; Gonzalo Alba; Víctor Sánchez-Margalet
Journal:  Biomedicines       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.